TNF-α has been shown to increase the antitumor activity of gemcitabine in pancreatic cancer (Murugesan et al., 2009); however, its curative effect does not seem to be perfect due to the activation of the NF-κB signaling pathway (Egberts et al., 2008). Here, NFKB1 is linked to pancreatic neoplasm.